| Polypill strategy in secondary cardiovascular prevention JM Castellano, SJ Pocock, DL Bhatt, AJ Quesada, R Owen, ... New England Journal of Medicine 387 (11), 967-977, 2022 | 178 | 2022 |
| Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial S Lanfranconi, E Scola, JMTA Meessen, R Pallini, GA Bertani, ... The Lancet Neurology 22 (1), 35-44, 2023 | 31 | 2023 |
| Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID‐19 patients with diabetes: a population‐based study in Lombardy L Ojeda‐Fernández, A Foresta, G Macaluso, P Colacioppo, M Tettamanti, ... Diabetes, Obesity and Metabolism 24 (5), 891-898, 2022 | 20 | 2022 |
| Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study M Baviera, A Foresta, P Colacioppo, G Macaluso, MC Roncaglioni, ... Cardiovascular Diabetology 21 (1), 162, 2022 | 19 | 2022 |
| Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction M Baviera, S Genovese, P Colacioppo, N Cosentino, A Foresta, ... Cardiovascular Diabetology 21 (1), 223, 2022 | 12 | 2022 |
| Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, and sodium-glucose cotransporter-2 inhibitors and COVID-19 outcomes A Foresta, L Ojeda-Fernandez, G Macaluso, MC Roncaglioni, ... Clinical Therapeutics 45 (4), e115-e126, 2023 | 7 | 2023 |
| Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study M Proietti, I Marzona, T Vannini, P Colacioppo, M Tettamanti, A Foresta, ... European Heart Journal-Cardiovascular Pharmacotherapy 7 (FI1), f84-f92, 2021 | 7 | 2021 |
| Effectiveness and safety of high and low dose NOACs in patients with atrial fibrillation I Marzona, M Proietti, P Colacioppo, A Foresta, M Baviera European journal of internal medicine 88, 118-122, 2021 | 3 | 2021 |
| UDCA treatment against COVID‐19: Do we have enough clinical evidence for drug repurposing? L Ojeda‐Fernández, M Baviera, G Macaluso, S Schena, M Tettamanti, ... Journal of Internal Medicine 295 (1), 110-112, 2024 | 2 | 2024 |
| Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study A Foresta, LO Fernandez, G Torrigiani, S Schena, MC Roncaglioni, ... Drugs & Aging, 1-11, 2024 | 1 | 2024 |
| Prescribing trends of glucose-lowering drugs in older adults from 2010 to 2021: A population-based study of Northern Italy A Foresta, E Succurro, M Baviera, G Macaluso, L Ojeda-Fernández, ... Diabetes Research and Clinical Practice 202, 110742, 2023 | 1 | 2023 |
| Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular … D Baldassarre, L Iacoviello, R Baetta, MC Roncaglioni, G Condorelli, ... BMJ open 13 (7), e072040, 2023 | 1 | 2023 |
| Impact of first and second/third wave of COVID-19 pandemic on post-acute cardiovascular outcomes in Lombardy L Ojeda-Fernández, M Baviera, A Foresta, M Tettamanti, A Zambon, ... Frontiers in Cardiovascular Medicine 10, 2023 | 1 | 2023 |
| Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study M Proietti, I Marzona, T Vannini, P Colacioppo, M Tettamanti, A Foresta, ... European Heart Journal 41 (Supplement_2), ehaa946. 0684, 2020 | 1 | 2020 |
| Prevalence and Predictors of Post-Acute COVID-19 Symptoms in Italian Primary Care Patients A Foresta, L Ojeda-Fernández, C Augurio, C Guanziroli, M Tettamanti, ... Journal of Primary Care & Community Health 15, 21501319231222364, 2024 | | 2024 |
| TEMPORARY REMOVAL: PO-36: The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer. A Foresta, P Colacioppo, M Baviera, L Ojeda-Fernandez, C Cimminiello Thrombosis Research 213, S27-S28, 2022 | | 2022 |
| The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer A Foresta, P Colacioppo, M Baviera, L Ojeda-Fernandez, C Cimminiello European Journal of Internal Medicine 99, 121-123, 2022 | | 2022 |
